Stock Scorecard



Stock Summary for Amarin Corp (AMRN) - $13.48 as of 9/22/2026 8:04:50 AM EST

Total Score

13 out of 30

Safety Score

22 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AMRN

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AMRN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AMRN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AMRN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AMRN (22 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 7
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for AMRN

Sarissa Capital Management and Alexander J. Denner Hold 25.7 Million Shares in Amarin Corporation (NASDAQ: AMRN) 9/2/2026 6:37:00 PM
Five abstracts from an 8,179-patient study are set for the 2026 heart congress 8/24/2026 12:13:00 PM
Amarin Announces REDUCE-IT-Related Presentations at ESC Congress 2026 in Munich 8/24/2026 12:13:00 PM
Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026 8/24/2026 7:10:00 AM
Amarin Stock Price Forecast. Should You Buy AMRN? 8/15/2026 6:11:00 PM
Q2 2026 Amarin Corporation PLC Earnings Call Transcript 8/5/2026 11:40:00 PM
Q1 2025 Amarin Corporation PLC Earnings Call Transcript 8/5/2026 11:40:00 PM
Amarin Corporation (AMRN) CFO equity award includes tax share withholding 8/3/2026 8:11:00 PM
Amarin reports Q2 2026: $42.2M revenue, $14.99M gross profit, $7.7M net loss, positive cash flow 8/2/2026 12:11:00 PM
Amarin Corp PLC (AMRN) Q2 2026 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges 8/1/2026 11:09:00 PM

Financial Details for AMRN

Company Overview

Ticker AMRN
Company Name Amarin Corp
Country N/A
Description Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - GENERAL
Most Recent Quarter 6/30/2026
Next Earnings Date 11/4/2026

Stock Price History

Last Day Price 13.48
Price 4 Years Ago 24.20
Last Day Price Updated 9/22/2026 8:04:50 AM EST
Last Day Volume 50,664
Average Daily Volume 71,189
52-Week High 20.90
52-Week Low 12.96
Last Price to 52 Week Low 4.01%

Valuation Measures

Trailing PE N/A
Industry PE 31.21
Sector PE 39.10
5-Year Average PE 5.56
Free Cash Flow Ratio 1.98
Industry Free Cash Flow Ratio 53.74
Sector Free Cash Flow Ratio 34.28
Current Ratio Most Recent Quarter 3.67
Total Cash Per Share 6.80
Book Value Per Share Most Recent Quarter 21.12
Price to Book Ratio 0.66
Industry Price to Book Ratio 14.97
Sector Price to Book Ratio 28.55
Price to Sales Ratio Twelve Trailing Months 1.57
Industry Price to Sales Ratio Twelve Trailing Months 4.96
Sector Price to Sales Ratio Twelve Trailing Months 23.22
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 21,122,800
Market Capitalization 284,735,344
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.12%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -94.20%
Annual Earnings Growth 52.79%
Reported EPS 12 Trailing Months -1.20
Reported EPS Past Year -0.57
Reported EPS Prior Year 0.27
Net Income Twelve Trailing Months -27,122,231
Net Income Past Year -38,798,000
Net Income Prior Year -82,183,000
Quarterly Revenue Growth YOY -42.00%
5-Year Revenue Growth -19.04%
Operating Margin Twelve Trailing Months -28.40%

Balance Sheet

Total Cash Most Recent Quarter 143,558,000
Total Cash Past Year 134,861,000
Total Cash Prior Year 121,038,000
Net Cash Position Most Recent Quarter 143,558,000
Net Cash Position Past Year 134,861,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 459,281,000
Total Stockholder Equity Prior Year 486,176,000
Total Stockholder Equity Most Recent Quarter 443,616,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 49,213,065
Free Cash Flow Per Share Twelve Trailing Months 2.33
Free Cash Flow Past Year 6,743,722
Free Cash Flow Prior Year -31,020,002

Options

Put/Call Ratio 0.42
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.32
MACD Signal -0.35
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.76
RSI 46.80
50-Day SMA 15.32
150-Day SMA 14.73
200-Day SMA 17.76

System

Modified 9/21/2026 5:12:17 PM EST